Literature DB >> 34040054

ADAMTS12 acts as a tumor microenvironment related cancer promoter in gastric cancer.

Yangming Hou1, Yingjuan Xu2, Dequan Wu3.   

Abstract

The infiltration degree of immune and stromal cells has been shown clinically significant in tumor microenvironment (TME). However, the utility of stromal and immune components in Gastric cancer (GC) has not been investigated in detail. In the present study, ESTIMATE and CIBERSORT algorithms were applied to calculate the immune/stromal scores and the proportion of tumor-infiltrating immune cell (TIC) in GC cohort, including 415 cases from The Cancer Genome Atlas (TCGA) database. The differentially expressed genes (DEGs) were screened by Cox proportional hazard regression analysis and protein-protein interaction (PPI) network construction. Then ADAMTS12 was regarded as one of the most predictive factors. Further analysis showed that ADAMTS12 expression was significantly higher in tumor samples and correlated with poor prognosis. Gene Set Enrichment Analysis (GSEA) indicated that in high ADAMTS12 expression group gene sets were mainly enriched in cancer and immune-related activities. In the low ADAMTS12 expression group, the genes were enriched in the oxidative phosphorylation pathway. CIBERSORT analysis for the proportion of TICs revealed that ADAMTS12 expression was positively correlated with Macrophages M0/M1/M2 and negatively correlated with T cells follicular helper. Therefore, ADAMTS12 might be a tumor promoter and responsible for TME status and tumor energy metabolic conversion.

Entities:  

Year:  2021        PMID: 34040054     DOI: 10.1038/s41598-021-90330-3

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  45 in total

1.  The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma.

Authors:  Lee A D Cooper; David A Gutman; Candace Chisolm; Christina Appin; Jun Kong; Yuan Rong; Tahsin Kurc; Erwin G Van Meir; Joel H Saltz; Carlos S Moreno; Daniel J Brat
Journal:  Am J Pathol       Date:  2012-03-20       Impact factor: 4.307

Review 2.  Glioblastoma: pathology, molecular mechanisms and markers.

Authors:  Kenneth Aldape; Gelareh Zadeh; Sheila Mansouri; Guido Reifenberger; Andreas von Deimling
Journal:  Acta Neuropathol       Date:  2015-05-06       Impact factor: 17.088

3.  Tumor microenvironment in head and neck squamous cell carcinoma.

Authors:  Joseph M Curry; John Sprandio; David Cognetti; Adam Luginbuhl; Voichita Bar-ad; Edmund Pribitkin; Madalina Tuluc
Journal:  Semin Oncol       Date:  2014-03-05       Impact factor: 4.929

4.  Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR.

Authors:  Nirosha Suraweera; Alex Duval; Maryline Reperant; Christelle Vaury; Daniela Furlan; Karen Leroy; Raquel Seruca; Barry Iacopetta; Richard Hamelin
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

5.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

6.  The immune score as a new possible approach for the classification of cancer.

Authors:  Jérôme Galon; Franck Pagès; Francesco M Marincola; Magdalena Thurin; Giorgio Trinchieri; Bernard A Fox; Thomas F Gajewski; Paolo A Ascierto
Journal:  J Transl Med       Date:  2012-01-03       Impact factor: 5.531

7.  Inferring tumour purity and stromal and immune cell admixture from expression data.

Authors:  Kosuke Yoshihara; Maria Shahmoradgoli; Emmanuel Martínez; Rahulsimham Vegesna; Hoon Kim; Wandaliz Torres-Garcia; Victor Treviño; Hui Shen; Peter W Laird; Douglas A Levine; Scott L Carter; Gad Getz; Katherine Stemke-Hale; Gordon B Mills; Roel G W Verhaak
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

8.  Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures.

Authors:  Yasin Şenbabaoğlu; Ron S Gejman; Andrew G Winer; Ming Liu; Eliezer M Van Allen; Guillermo de Velasco; Diana Miao; Irina Ostrovnaya; Esther Drill; Augustin Luna; Nils Weinhold; William Lee; Brandon J Manley; Danny N Khalil; Samuel D Kaffenberger; Yingbei Chen; Ludmila Danilova; Martin H Voss; Jonathan A Coleman; Paul Russo; Victor E Reuter; Timothy A Chan; Emily H Cheng; David A Scheinberg; Ming O Li; Toni K Choueiri; James J Hsieh; Chris Sander; A Ari Hakimi
Journal:  Genome Biol       Date:  2016-11-17       Impact factor: 13.583

Review 9.  Epidemiology of gastric cancer and risk factors.

Authors:  Ottavia Cavatorta; Serena Scida; Chiara Miraglia; Alberto Barchi; Antonio Nouvenne; Gioacchino Leandro; Tiziana Meschi; Gian Luigi De' Angelis; Francesco Di Mario
Journal:  Acta Biomed       Date:  2018-12-17

Review 10.  Targeted literature review of the global burden of gastric cancer.

Authors:  Montserrat Casamayor; Robert Morlock; Hiroshi Maeda; Jaffer Ajani
Journal:  Ecancermedicalscience       Date:  2018-11-26
View more
  3 in total

1.  The LINC01929/miR-6875-5p/ADAMTS12 Axis in the ceRNA Network Regulates the Development of Advanced Bladder Cancer.

Authors:  YuFeng Xiong; MingRui Pang; Yang Du; Xi Yu; JingPing Yuan; Wen Liu; Lei Wang; XiuHeng Liu
Journal:  Front Oncol       Date:  2022-05-12       Impact factor: 5.738

2.  Phosphoserine phosphatase as a prognostic biomarker in patients with gastric cancer and its potential association with immune cells.

Authors:  Ma-Yan Huang; Xiao-Yun Liu; Qiong Shao; Xu Zhang; Lei Miao; Xiao-Yan Wu; Yu-Xia Xu; Fang Wang; Hai-Yun Wang; Liang Zeng; Ling Deng
Journal:  BMC Gastroenterol       Date:  2022-01-03       Impact factor: 3.067

3.  A combined analysis of bulk and single-cell sequencing data reveals that depleted extracellular matrix and enhanced immune processes co-contribute to fluorouracil beneficial responses in gastric cancer.

Authors:  Shaowei Dong; Siyu Zhang; Pan Zhao; Guanchuan Lin; Xiaoshi Ma; Jing Xu; Hao Zhang; Jiliang Hu; Chang Zou
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.